Henry Hagopian III serves as Executive at Organogenesis Holdings Inc., where they oversee executive responsibilities. Since joining the company, Henry Hagopian III has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 20, 2023 involved receiving (via award) 824 shares valued at $5.0K.
Henry Hagopian III currently holds 1,824 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henry Hagopian III has been a net neutral trader of ORGO stock. They have purchased $0 and sold $0 worth of shares.
Henry Hagopian III's most recent insider trade was on Nov 20, 2023, when they sold 824 shares at $6.07 per share.
Get notified when new Form 4 filings are submitted
| $6.10 |
| Discretionary |
| Apr 7, 2023 | ANVS | $12.6K | Award | 1,000 | $12.61 | Discretionary |
| Jan 13, 2021 | ORGO | $0 | Award | 10,700 | $N/A | Discretionary |